SpliSense addressed the underlying genetic cause of the disease, thereby offering hope of restoring the defective protein and generating adequate lung function in patients suffering from CF.
By JNi.Media
According to the National Institutes of Health (NIH), nearly one in five people of Ashkenazi Jewish descent are carriers of a Jewish genetic disorder.